Follow The Filings

MDGL position history

The shares of Madrigal Pharmaceuticals (MDGL) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q3: 2,600 shares, $1.2M, <0.01% of portfolio, New
  2. 2025 Q4: 2,500 shares, $1.5M, <0.01% of portfolio, Reduce −3.8%
  3. 2026 Q1: 5,300 shares, $2.8M, <0.01% of portfolio, Add +112.0%
  4. 2026 Q2: 4,500 shares, $2.4M, <0.01% of portfolio, Reduce −15.1%
Holdings date Value % of holdings Shares Filing date All 13F holders